Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Splash Clinical Achieves Record Growth Supported by Innovative Patient Recruitment Tools


News provided by

Splash Clinical

Sep 19, 2023, 09:00 ET

Share this article

Share toX

Share this article

Share toX


Company Reports Record Growth and Revenue Growth After Expanding Reach in the APAC Region

WAUWATOSA, Wis., Sept. 19, 2023 /PRNewswire-PRWeb/ --Splash Clinical, the new standard in patient recruitment solutions, today announced a 429% growth rate in revenue over the past three years and 82% workforce growth. The significant growth comes after the company expanded its role in supporting global clinical trials, particularly in the emerging Asia-Pacific (APAC) region, where it has launched multiple recruitment campaigns. During this time, Splash Clinical has introduced patient-centric technology tools to help streamline the process for individuals considering enrollment in clinical trials.

The patient recruitment landscape for clinical studies presents both challenges and opportunities. With nearly 80% of all clinical studies failing to conclude on schedule and one-fifth of those being delayed by six months or more, the industry faces significant hurdles. The average dropout rate stands at 30%, and the struggle is evident, with over two-thirds of sites not meeting their original patient enrollment targets. Despite these challenges, the global clinical trials market is on a growth trajectory. As of 2022, it was valued at USD 53.92 Billion, and projections indicate an increase to USD 85.01 Billion by 2030, a CAGR of 5.93%. This growth underscores the increasing global emphasis on clinical trials and the urgent need for innovative solutions to address patient recruitment and retention.

At Splash Clinical, we've redefined patient recruitment. This has enabled patients from around the world to discover clinical studies effortlessly while scrolling through their feeds, helping us fulfill our ultimate goal: helping our clients meet their recruiting goals quickly and consistently.

Post this

In the last three years, Splash Clinical has seen a remarkable revenue growth of 429%, bolstered its workforce by 82%, and expanded its global presence to the APAC region. This significant momentum is a testament to the company's commitment to the acceleration and success of clinical trials worldwide. Splash Clinical's surge in growth underscores the essential role the company plays in expediting clinical trials. Every delay in a clinical study can potentially push back the release of vital treatments to patients who need them. Splash's Clinical growth is tangibly impacting the speed and efficiency of drug development and delivery.

A critical factor in this success is Splash Clinical's innovative approach to patient recruitment.

"At Splash Clinical, we've redefined patient recruitment by tapping into the power of social media, digital media, mobile technologies, and real-time analytics," said Matt Teuteberg, President and CEO of Splash Clinical. "This has enabled patients from around the world to discover clinical studies effortlessly while scrolling through their feeds, helping us fulfill our ultimate goal: helping our clients meet their recruiting goals quickly and consistently."

One of the innovations behind this growth is Splash Clinical's call center service, designed to perform secondary phone screenings of patients and direct them to appropriate trial sites. The service aims to relieve some of the burden on sites already tasked with the complexities of managing clinical trials. Unlike similar services from competitors, Splash Clinical's call center leverages advanced scheduling technology, analytics for targeted screenings, and a "white glove" approach that includes trial education support for patients. According to company metrics, the call center has contributed to a 69% increase in screening rates for sites that use the service. This increase is significant for the efficiency of both the sites and the studies involved. This tool aligns perfectly with Splash Clinical's mission of prioritizing patients and offering a seamless enrollment experience.

Splash's commitment to combining advanced technology with genuine empathy provides a unique edge in patient recruitment. Moreover, precision targeting remains a central component of Splash Clinical's strategy. The company believes in creating clinical studies that mirror the diverse world we live in to address health disparities. By creating campaigns that resonate with patients in diverse geographies, Splash Clinical can engage with patients effectively and enroll them in studies tailored to their unique needs.

With a history of providing high-quality referrals and enrolling patients in clinical studies across the globe, Splash Clinical's continued growth and innovative features solidify its position as a trailblazer in patient recruitment.

To learn more, please visit splashclinical.com/

About Splash Clinical

Splash Clinical is the new standard in patient recruitment solutions. We transform recruitment processes, setting a new benchmark for the industry. Combining the powers of digital media, mobile technologies, social media, and real-time analytics, our unique recruiting methodology has successfully expedited enrollment for clinical studies worldwide.

Splash Clinical delivers precision-targeted patient recruitment strategies, meeting the unique demands of Sponsors, Contract Research Organizations (CROs), and Sites. We ensure that our partners can focus on the vital task of advancing medical research while we take care of securing high-quality patient referrals for each study. With transparency embedded into our approach, we provide clients with real-time performance insights, stripping the recruitment landscape of any surprises.

While we employ cutting-edge digital solutions, our real edge comes from our people-centric approach. At the heart of Splash Clinical is a team that goes above and beyond to understand our clients' needs, providing a level of service that sets us apart from the competition. As a result, we deliver personalized services and foster strong relationships in the pursuit of accelerating clinical research to improve human health.

Splash Clinical was founded in 2011 and is proudly based in Wauwatosa, WI. To learn more, please visit https://splashclinical.com/.

Splash Clinical. Redefining Patient Recruitment.

Media Contact

Juan Avila, Splash Clinical, 5125894486, [email protected], https://splashclinical.com/

SOURCE Splash Clinical

Modal title

Splash Clinical
Splash Clinical
Splash Clinical

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.